Definition
C1 inhibitor (C1-INH) is a serine protease inhibitor intimately involved in the regulation of the complement cascade and the contact system. Heterozygous deficiency of C1-INH is the most common cause of hereditary angioedema.
The Deficiency of C1 Inhibitor
C1-INH was first identified in the late 1950s as the serum inhibitor of C1 esterase (Levy and Lepow 1959). Today we know that it inhibits other serine proteases in various enzymatic systems. When the levels of C1-INH fall below 50% of normal, the contact system is exposed to inappropriate activation with local release of bradykinin, increase of endothelial permeability, fluid extravasation, and edema formation (Fig. 1). The most common cause of C1-INH deficiency are mutations in its coding gene SERPING1. An acquired deficiency of C1-INH, with identical clinical features, has also been described (Caccia et al. 2014). Genetic deficiency of C1-INH with angioedema symptoms (C1-INH-HAE) has a prevalence around 1:50,000...
References
Bafunno V, Divella C, Sessa F, Tiscia GL, Castellano G, Gesualdo L, et al. De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema. J Allergy Clin Immunol. 2013;132:748.
Banerji et al. Inhibiting plasma kallikrein for hereditary angioedema prophylaxis. N Engl J Med. 2017;376:717–28.
Bhardwaj N, Craig TJ. Treatment of hereditary angioedema: a review. Transfusion. 2014;54:2989.
Bork K, Hardt J, Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012;130(3):692–7.
Bork K. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. Immunotherapy. 2014;6(5):533–51.
Caccia S, Suffritti C, Cicardi M. Pathophysiology of hereditary angioedema. Pediatr Allergy Immunol Pulmonol. 2014;27(4):159–63.
Cumming SA, Halsall DJ, Ewan PW, Lomas DA. The effect of sequence variations within the coding region of the C1 inhibitor gene on disease expression and protein function in families with hereditary angio-oedema. J Med Genet. 2003;40(10):e114.
Farkas H. Current pharmacotherapy of bradykinin-mediated angioedema. Expert Opin Pharmacother. 2013;14(5):571–86.
Kaplan AP, Joseph K. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol. 2014;121:41–89.
Levy LR, Lepow IH. Assay and properties of serum inhibitor of C'l-esterase. Proc Soc Exp Biol Med. 1959;101:608–11.
Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet. 2012;379(9814):474–81.
Longhurst et al. Prevention of hereditary angioedema attacks with subcutaneous C1 inhibitor. N Engl J Med. 2017;376:1131–40.
Mansi M, Zanichelli A, Coerezza A, Suffritti C, Wu MA, Vacchini R, et al. Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients. J Intern Med. 2015;277(5):585–93.
Nussberger J, Cugno M, Cicardi M. Bradykinin-mediated angioedema. N Engl J Med. 2002;347(8):621–2.
Riedl MA. Critical appraisal of androgen use in hereditary angioedema: a systematic review. Ann Allergy Asthma Immunol. 2015;114(4):281–8. e7
Tosi M, Carugati A, Hernandez C, Boucontet L, Pappalardo E, Agostoni A, et al. De novo C1 inhibitor mutations in hereditary angioedema. Mol Immunol. 1998;35(6–7):406.
Zanichelli A, Arcoleo F, Barca MP, Borrelli P, Bova M, Cancian M, et al. A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy. Orphanet J Rare Dis. 2015;10:11.
Zuraw BL, Cicardi M, Longhurst HJ, Bernstein JA, Li HH, Magerl M, et al. Phase II study results of a replacement therapy for hereditary angioedema (HAE) with subcutaneous C1-inhibitor concentrate. Allergy. 2015;70:1319.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media LLC
About this entry
Cite this entry
Cicardi, M., Zanichelli, A., Suffritti, C., Wu, M., Caccia, S. (2016). Hereditary Deficiency of C1 Inhibitor and Angioedema. In: MacKay, I., Rose, N. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9209-2_4-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9209-2_4-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9209-2
Online ISBN: 978-1-4614-9209-2
eBook Packages: Springer Reference MedicineReference Module Medicine